Literature DB >> 19405217

Virulence mechanisms of Moraxella in the pathogenesis of infection.

M Laura Perez Vidakovics1, Kristian Riesbeck.   

Abstract

PURPOSE OF REVIEW: Moraxella catarrhalis is an emerging human-specific pathogen responsible for upper and lower respiratory tract infections. Understanding the events in the complex pathogenesis and underlying mechanisms during M. catarrhalis infection is a key to the development of novel therapeutics and vaccines. RECENT
FINDINGS: Several novel findings have been reported on Moraxella pathogenesis and, in parts, explain how the species stands as a commensal in preschool children and survives in the host. Molecular structures for different adhesins in addition to target ligands with respect to signalling and invasion have been defined. Evasion of the complement system allows Moraxella to survive in the mucosa and by neutralizing [alpha]1-antichymotrypsin the protease activity is increased, resulting in tissue destruction and thus promotion of bacterial attachment. Moraxella-dependent cell activation via immunoglobulin D in addition to toll-like receptors and specific epithelial cell inhibition by cross-linking of carcinoembryonic antigen-related cell adhesion molecule-1 in the early innate immune response and, finally, the ability of M. catarrhalis to form biofilms are other specific research areas of interest.
SUMMARY: Recent advances have allowed a more detailed picture of the processes involved in bacteria-host cell interactions, the cause of inflammatory processes and specific host defense responses against the intriguing species Moraxella.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19405217     DOI: 10.1097/qco.0b013e3283298e4e

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  16 in total

1.  Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen.

Authors:  Stefan P W de Vries; Sacha A F T van Hijum; Wolfgang Schueler; Kristian Riesbeck; John P Hays; Peter W M Hermans; Hester J Bootsma
Journal:  J Bacteriol       Date:  2010-05-07       Impact factor: 3.490

2.  Role of the oligopeptide permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract.

Authors:  Megan M Jones; Antoinette Johnson; Mary Koszelak-Rosenblum; Charmaine Kirkham; Aimee L Brauer; Michael G Malkowski; Timothy F Murphy
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin.

Authors:  Viveka Schaar; Therése Nordström; Matthias Mörgelin; Kristian Riesbeck
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

4.  Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma.

Authors:  Kathryn McCauley; Juliana Durack; Ricardo Valladares; Douglas W Fadrosh; Din L Lin; Agustin Calatroni; Petra K LeBeau; Hoang T Tran; Kei E Fujimura; Brandon LaMere; Geil Merana; Kole Lynch; Robyn T Cohen; Jacqueline Pongracic; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Michelle Gill; Andrew H Liu; Haejin Kim; Meyer Kattan; Stephen J Teach; Alkis Togias; Homer A Boushey; James E Gern; Daniel J Jackson; Susan V Lynch
Journal:  J Allergy Clin Immunol       Date:  2019-06-13       Impact factor: 10.793

5.  Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates.

Authors:  Jeremiah J Davie; Josh Earl; Stefan P W de Vries; Azad Ahmed; Fen Z Hu; Hester J Bootsma; Kim Stol; Peter W M Hermans; Robert M Wadowsky; Garth D Ehrlich; John P Hays; Anthony A Campagnari
Journal:  BMC Genomics       Date:  2011-01-26       Impact factor: 3.969

6.  Topical curcumin can inhibit deleterious effects of upper respiratory tract bacteria on human oropharyngeal cells in vitro: potential role for patients with cancer therapy induced mucositis?

Authors:  Sonja Lüer; Rolf Troller; Marion Jetter; Violeta Spaniol; Christoph Aebi
Journal:  Support Care Cancer       Date:  2010-05-14       Impact factor: 3.603

7.  Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.

Authors:  Dabin Ren; Shengqing Yu; Song Gao; Daxin Peng; Ronald S Petralia; Artur Muszynski; Russell W Carlson; John B Robbins; Chao-Ming Tsai; David J Lim; Xin-Xing Gu
Journal:  Vaccine       Date:  2011-04-16       Impact factor: 3.641

8.  ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence.

Authors:  Timothy F Murphy; Aimee L Brauer; Antoinette Johnson; Charmaine Kirkham
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

9.  B cell activation by outer membrane vesicles--a novel virulence mechanism.

Authors:  Maria Laura A Perez Vidakovics; Johan Jendholm; Matthias Mörgelin; Anne Månsson; Christer Larsson; Lars-Olaf Cardell; Kristian Riesbeck
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

10.  Alterations in oral microbial flora induced by waterpipe tobacco smoking.

Authors:  Muhamad Ali K Shakhatreh; Omar F Khabour; Karem H Alzoubi; Majed M Masadeh; Emad I Hussein; George N Bshara
Journal:  Int J Gen Med       Date:  2018-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.